AegirBio
Aegirbio signs agreement with Salofa for the veterinary market and receives a first order worth approximately SEK 2 million.
With this agreement, AegirBio will, via its subsidiary Magnasense Technologies OY, sell its existing MagniaReader to Salofa, which will bring it to market with proprietary tests for horses, dogs and cats. Magnasense receives revenue from the sale of instruments and royalties on the disposable products ie. tests that Salofa sells for the instruments.
When the contract was signed, an order was added to the value of 195,000 Euro (approx. SEK 2 million) for year one.
| Datum | 2023-07-07, kl 10:00 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!